<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33651791</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>06</Month>
        <Day>28</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>06</Month>
        <Day>28</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1935-2735</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>15</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>PLoS neglected tropical diseases</Title>
          <ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Emerging high-level ciprofloxacin-resistant Salmonella enterica serovar typhi haplotype H58 in travelers returning to the Republic of Korea from India.</ArticleTitle>
        <Pagination>
          <StartPage>e0009170</StartPage>
          <MedlinePgn>e0009170</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e0009170</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0009170</ELocationID>
        <Abstract>
          <AbstractText>In Korea, typhoid fever is a rare disease due to improved living standards. However, typhoid fever remains a major burden in developing countries and regions, such as India and Southeast Asia. In this study, we isolated Salmonella Typhi (S. Typhi) from eight patients with typhoid fever who were travelers returning from India. The strains isolated were characterized by antimicrobial susceptibility profiling and whole-genome sequencing (WGS) analysis. All strains were resistant to nalidixic acid and azithromycin. Among them, four isolates were highly resistant to ciprofloxacin (MIC ≥32 μg/ml); these strains have not been confirmed in Korea PulseNet DB. According to WGS, the ciprofloxacin-resistant strains belong to the global dominant multidrug-resistant (MDR) haplotype H58 (SNP glpA C1047T, SptP protein Q185* (premature stop codon)) and do not harbor the MDR plasmid. H58-associated SNPs in membrane and metabolism genes, including yhdA, yajI, hyaE, tryE, rlpB and metH, are present. Additionally, phylogenetic analysis assigned the H58 strains to sublineage II, whereas the non-H58 strains are closely related to haplotype H50. The presence of high-level ciprofloxacin-resistant S. Typhi haplotype H58 in Korea was first confirmed as due to influx from overseas via travelers. This study provides information about intercontinental drug-resistant transmission between countries and suggests that travelers need to be careful about personal hygiene.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Shin</LastName>
            <ForeName>Eunkyung</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Bacterial Diseases, Korea Centers for Diseases Control and Prevention, Cheongju, Republic of Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>College of Veterinary Medicine, Chungnam National University, Daejeon, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Park</LastName>
            <ForeName>Jungsun</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Bacterial Diseases, Korea Centers for Diseases Control and Prevention, Cheongju, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jeong</LastName>
            <ForeName>Hyun Ju</ForeName>
            <Initials>HJ</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Bacterial Diseases, Korea Centers for Diseases Control and Prevention, Cheongju, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Park</LastName>
            <ForeName>Ae Kyung</ForeName>
            <Initials>AK</Initials>
            <Identifier Source="ORCID">0000-0002-6898-9340</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Bacterial Diseases, Korea Centers for Diseases Control and Prevention, Cheongju, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Na</LastName>
            <ForeName>Kyoungin</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Diseases Control, Korea Centers for Diseases Control and Prevention, Cheongju, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Hyerim</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Diseases Control, Korea Centers for Diseases Control and Prevention, Cheongju, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chun</LastName>
            <ForeName>Jeong-Hoon</ForeName>
            <Initials>JH</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Bacterial Diseases, Korea Centers for Diseases Control and Prevention, Cheongju, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hwang</LastName>
            <ForeName>Kyu Jam</ForeName>
            <Initials>KJ</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Bacterial Diseases, Korea Centers for Diseases Control and Prevention, Cheongju, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Chul-Joong</ForeName>
            <Initials>CJ</Initials>
            <AffiliationInfo>
              <Affiliation>College of Veterinary Medicine, Chungnam National University, Daejeon, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Junyoung</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0003-3368-291X</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Bacterial Diseases, Korea Centers for Diseases Control and Prevention, Cheongju, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>03</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>PLoS Negl Trop Dis</MedlineTA>
        <NlmUniqueID>101291488</NlmUniqueID>
        <ISSNLinking>1935-2727</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>5E8K9I0O4U</RegistryNumber>
          <NameOfSubstance UI="D002939">Ciprofloxacin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002939" MajorTopicYN="N">Ciprofloxacin</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024901" MajorTopicYN="Y">Drug Resistance, Multiple, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012485" MajorTopicYN="N">Salmonella typhi</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000076082" MajorTopicYN="N">Travel-Related Illness</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014435" MajorTopicYN="N">Typhoid Fever</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>1</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>2</Day>
          <Hour>17</Hour>
          <Minute>8</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33651791</ArticleId>
        <ArticleId IdType="pmc">PMC7987170</ArticleId>
        <ArticleId IdType="doi">10.1371/journal.pntd.0009170</ArticleId>
        <ArticleId IdType="pii">PNTD-D-20-00697</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Crump JA, Mintz ED. Global Trends in Typhoid and Paratyphoid Fever. Clin Infect Dis. 2010;50(2):241–6. 10.1086/649541
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/649541</ArticleId>
            <ArticleId IdType="pmc">PMC2798017</ArticleId>
            <ArticleId IdType="pubmed">20014951</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mogasale V, Maskery B, Ochiai RL, Lee JS, Mogasale V V., Ramani E, et al.. Burden of typhoid fever in low-income and middle-income countries: A systematic, literature-based update with risk-factor adjustment. Lancet Glob Heal [Internet]. 2014;2(10):e570–80. Available from: 10.1016/S2214-109X(14)70301-8
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2214-109X(14)70301-8</ArticleId>
            <ArticleId IdType="pubmed">25304633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dyson ZA, Klemm EJ, Palmer S, Dougan G. Antibiotic Resistance and Typhoid. Clin Infect Dis. 2019;68(2):S165–70. 10.1093/cid/ciy1111
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciy1111</ArticleId>
            <ArticleId IdType="pmc">PMC6405283</ArticleId>
            <ArticleId IdType="pubmed">30845331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong VK, Baker S, Pickard DJ, Parkhill J, Page AJ, Feasey NA, et al.. Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter-and intracontinental transmission events. Nat Genet. 2015;47(6):632–9. 10.1038/ng.3281
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng.3281</ArticleId>
            <ArticleId IdType="pmc">PMC4921243</ArticleId>
            <ArticleId IdType="pubmed">25961941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park SE, Pham DT, Boinett C, Wong VK, Pak GD, Panzner U, et al.. The phylogeography and incidence of multi-drug resistant typhoid fever in sub-Saharan Africa. Nat Commun. 2018;9(1). 10.1038/s41467-018-07370-z
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-018-07370-z</ArticleId>
            <ArticleId IdType="pmc">PMC6269545</ArticleId>
            <ArticleId IdType="pubmed">30504848</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thanh DP, Karkey A, Dongol S, Thi NH, Thompson CN, Rabaa MA, et al.. A novel ciprofloxacin-resistant subclade of h58. Salmonella typhi is associated with fluoroquinolone treatment failure. Elife. 2016;5(MARCH2016):1–13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4805543</ArticleId>
            <ArticleId IdType="pubmed">26974227</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steinberg EB, Bishop R, Haber P, Dempsey AF, Hoekstra RM, Nelson JM, et al.. Typhoid fever in travelers: Who should be targeted for prevention?
Clin Infect Dis. 2004;39(2):186–91. 10.1086/421945
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/421945</ArticleId>
            <ArticleId IdType="pubmed">15307027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Brien DP, Leder K, Matchett E, Brown G V., Torresi J. Illness in returned travelers and immigrants/refugees: The 6-year experience of two Australian infectious diseases units. J Travel Med. 2006;13(3):145–52. 10.1111/j.1708-8305.2006.00033.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1708-8305.2006.00033.x</ArticleId>
            <ArticleId IdType="pubmed">16706945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nüesch-Inderbinen M, Abgottspon H, Sägesser G, Cernela N, Stephan R. Antimicrobial susceptibility of travel-related Salmonella enterica serovar Typhi isolates detected in Switzerland (2002–2013) and molecular characterization of quinolone resistant isolates. BMC Infect Dis. 2015;15(1):1–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4435775</ArticleId>
            <ArticleId IdType="pubmed">25963025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chatham-Stephens K, Medalla F, Hughes M, Appiah GD, Aubert RD, Caidi H, et al.. Emergence of Extensively Drug-Resistant Salmonella Typhi Infections Among Travelers to or from Pakistan—United States, 2016–2018. MMWR Morb Mortal Wkly Rep. 2019;68(1):11–3. 10.15585/mmwr.mm6801a3
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.15585/mmwr.mm6801a3</ArticleId>
            <ArticleId IdType="pmc">PMC6342547</ArticleId>
            <ArticleId IdType="pubmed">30629573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Korea Centers for Disease Control and Prevention (KCDC). Incidence of Legal infectious disease in national monitoring index [Internet]. http://www.index.go.kr/potal/main/EachDtlPageDetail.do?idx_cd=1442</Citation>
        </Reference>
        <Reference>
          <Citation>Clinical and Laboratory Standards Institute (CLSI)
Performance standards for antimicrobial susceptibility testing. M100
28th edition. Wayne, PA. 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Korea Centers for Disease Control and Prevention (KCDC). Korea infectious disease portal [Internet]. http://www.cdc.go.kr/npt/biz/npp/ist/bass/bassDissStatsMain.do</Citation>
        </Reference>
        <Reference>
          <Citation>Wirth T. Massive lineage replacements and cryptic outbreaks of Salmonella Typhi in eastern and southern Africa. Nat Genet. 2015;47(6):565–7. 10.1038/ng.3318
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng.3318</ArticleId>
            <ArticleId IdType="pubmed">26018894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Renuka K, Sood S, Das BK, Kapil A. High-level ciprofloxacin resistance in Salmonella enterica serotype Typhi in India. Vol. 54, Journal of Medical Microbiology. 2005. p. 999–1000. 10.1099/jmm.0.45966-0
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/jmm.0.45966-0</ArticleId>
            <ArticleId IdType="pubmed">16157558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim D-B, Kim S-H, Oh S-J, Kim D-K, Choi S-M, Kim M-S, et al.. Three cases of ciprofloxacin treatment failure in imported typhoid fever. Korean J Med. 2009;77(3):377–81.</Citation>
        </Reference>
        <Reference>
          <Citation>Klemm EJ, Shakoor S, Page AJ, Qamar FN, Judge K, Saeed DK, et al.. Emergence of an extensively drug-resistant Salmonella enterica serovar typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins. MBio. 2018;9(1):1–10. 10.1128/mBio.00105-18
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.00105-18</ArticleId>
            <ArticleId IdType="pmc">PMC5821095</ArticleId>
            <ArticleId IdType="pubmed">29463654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>India: Two dozen typhoid cases reported in Krishna district, Vijayawada [Internet]. Promed. 2017. https://promedmail.org/promed-posts/, Archive Number: 20170808.5235812</Citation>
        </Reference>
        <Reference>
          <Citation>Johnson R, Byrne A, Berger CN, Klemm E, Crepin VF, Dougan G, et al.. The type III secretion system effector SptP of Salmonella enterica serovar Typhi. J Bacteriol. 2017;199(4):1–18. 10.1128/JB.00647-16
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.00647-16</ArticleId>
            <ArticleId IdType="pmc">PMC5287405</ArticleId>
            <ArticleId IdType="pubmed">27920299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ingle DJ, Nair S, Hartman H, Ashton PM, Dyson ZA, Day M, et al.. Informal genomic surveillance of regional distribution of Salmonella Typhi genotypes and antimicrobial resistance via returning travellers. PLoS Negl Trop Dis [Internet]. 2019;13(9):1–20. Available from: 10.1371/journal.pntd.0007620
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pntd.0007620</ArticleId>
            <ArticleId IdType="pmc">PMC6741848</ArticleId>
            <ArticleId IdType="pubmed">31513580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holt KE, Dolecek C, Chau TT, Duy PT, la TTP, van Minh Hoang N, et al.. Temporal fluctuation of multidrug resistant Salmonella typhi haplotypes in the mekong river delta region of Vietnam. PLoS Negl Trop Dis. 2011;5(1):1–10. 10.1371/journal.pntd.0000929
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pntd.0000929</ArticleId>
            <ArticleId IdType="pmc">PMC3014949</ArticleId>
            <ArticleId IdType="pubmed">21245916</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
